Endo International plc: Endo Reports Third-Quarter 2021 Fina

DUBLIN, Nov. 4, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2021. "We delivered strong third-quarter

Related Keywords

Canada , Dublin , Ireland , Canadian , Blaise Coleman , Prnewswire Endo International , Company Net , Branded Pharmaceuticals , Company Net Debt Leverage Ratio , Linkedin , Generic Pharmaceuticals , Endo Investor Relations Department , Nasdaq , Exchange Commission , International Pharmaceuticals , Pfizer Inc , Endo International , Strides Pharma Science , Company Loss , Chief Executive Officer , Months Ended September , Diluted Net , Continuing Operations , Diluted Weighted Average Shares , Diluted Net Income , Adjusted Diluted Weighted Average Shares , Adjusted Income , Sterile Injectables , Note Regarding Forward Looking Statements , Operating Expenses , Total Revenues , Chestnut Ridge , Strides Pharma Science Limited , Condensed Consolidated Statement , Condensed Consolidated Balance Sheet , Cash Flow , Qualified Settlement , Current Report , Supplemental Financial Information , Condensed Consolidated Statements , Net Debt Leverage Ratio , Net Debt , Restricted Cash , Net Debt Leverage , Debt Leverage Ratio , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Kendo , Nternational , Reports , Third , Quarter , 021 , Financial , Results , Raises , Guidance ,